Browsing Category
Pharma Industry News
4753 posts
Business-News-Today.com section for global pharma industry news, Indian pharma sector latest news, pharma sector news today, pharmaceuticals industry news.
ACON investments completes strategic exit from Vitalis in major Latin American pharmaceutical deal
ACON Investments, L.L.C., a Washington, D.C.-based international private equity investment firm, has announced the completion of the sale…
AceLink Therapeutics’ AL01211 shows promising results in Phase 2 Fabry disease trial
AceLink Therapeutics, Inc., a clinical-stage biotechnology company focused on next-generation therapies, has released promising interim data from its…
Aurobindo Pharma achieves record revenue in Q3 FY25 despite profit decline
Aurobindo Pharma Limited has reported its highest-ever quarterly revenue for the third quarter of fiscal year 2025, underlining…
AptarGroup’s earnings soar 62% in Q4—see what’s driving the growth
AptarGroup, Inc., a global leader in drug and consumer product dosing, dispensing, and protection technologies, has reported robust…
Palatin Technologies completes Phase 2 obesity trial with MC4R bremelanotide and GLP-1/GIP tirzepatide
Palatin Technologies, Inc. has announced the completion of its Phase 2 BMT-801 clinical trial, a study evaluating the…
Lipella Pharmaceuticals secures FDA approval for expanded access program for LP-310 in oral lichen planus
Lipella Pharmaceuticals Inc., a clinical-stage biotechnology company dedicated to addressing unmet medical needs, has announced that it has…
Akeso advances cancer immunotherapy as Ivonescimab reaches Phase III milestone in lung cancer treatment
Akeso, Inc. (9926.HK) has completed patient enrollment for its pivotal Phase III trial (HARMONi-6), marking a significant step…
Zydus Lifesciences posts strong Q3 FY25 results with 30% net profit surge
Zydus Lifesciences Limited has reported robust financial performance for the third quarter of fiscal year 2025, driven by…
Pasithea Therapeutics advances cancer trial after positive safety review of PAS-004
Pasithea Therapeutics Corp. (NASDAQ: KTTA) has reached a significant milestone in its Phase 1 clinical trial of PAS-004,…
Amgen reports strong Q4 growth amid expanding product sales and biotech innovations
Amgen’s revenue growth for the fourth quarter of 2024 exceeded analyst expectations, reflecting the company’s expanding biopharmaceutical portfolio…